GWSG
REGN icon

GPS Wealth Strategies Group’s Regeneron Pharmaceuticals REGN Stock Holding History

GPS Wealth Strategies Group’s Portfolio REGN Stock Details REGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q4 		$91.8K Sell
119
-312
-72% -$212K 0.08% 158
2025
Q3 		$242K Sell
431
-16
-4% -$9.05K 0.03% 312
2025
Q2 		$235K Sell
447
-53
-11% -$29.6K 0.03% 302
2025
Q1 		$317K Sell
500
-71
-12% -$48.8K 0.04% 234
2024
Q4 		$407K Sell
571
-60
-10% -$50.4K 0.05% 198
2024
Q3 		$664K Buy
631
+37
+6% +$41.2K 0.09% 150
2024
Q2 		$625K Buy
594
+82
+16% +$79.5K 0.09% 134
2024
Q1 		$492K Sell
512
-1
-0.2% -$951 0.08% 155
2023
Q4 		$451K Buy
513
+70
+16% +$57.6K 0.08% 159
2023
Q3 		$365K Buy
443
+35
+9% +$27.5K 0.07% 174
2023
Q2 		$293K Buy
408
+153
+60% +$118K 0.05% 201
2023
Q1 		$210K Buy
+255
New +$192K 0.04% 234
2022
Q4 		– Sell
-229
Closed -$158K – 867
2022
Q3 		$158K Sell
229
-2
-0.9% -$1.26K 0.04% 233
2022
Q2 		$137K Sell
231
-11
-5% -$7.15K 0.04% 261
2022
Q1 		$169K Buy
242
+19
+9% +$12K 0.04% 232
2021
Q4 		$141K Buy
223
+27
+14% +$16.6K 0.03% 247
2021
Q3 		$119K Buy
196
+64
+48% +$39.7K 0.03% 257
2021
Q2 		$74K Hold
132
– – 0.02% 347
2021
Q1 		$62K Buy
+132
New +$64.3K 0.02% 346

Other funds holding REGN

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Dodge & Cox
Dodge & Cox San Francisco, California $191B AUM 17.5% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Nuveen
Nuveen Charlotte, North Carolina $419B AUM 43.02% 1-Year Est. Return

GPS Wealth Strategies Group's REGN Position: Q4 2025 in Review

GPS Wealth Strategies Group reduced its Regeneron Pharmaceuticals (REGN) stake by 72% in Q4 2025, selling an estimated $212K and leaving 119 shares worth $91.8K. The position accounts for 0.08% of the portfolio, ranked #158.

GPS Wealth Strategies Group first reported a position in REGN in Q1 2021 and has held it in 19 quarters since. The position peaked at $664K in Q3 2024. 1,388 funds tracked by Wall St. Rank hold REGN as of Q4 2025.

  • GPS Wealth Strategies Group held 119 shares of Regeneron Pharmaceuticals worth $91.8K as of Q4 2025.
  • GPS Wealth Strategies Group sold 312 Regeneron Pharmaceuticals shares in Q4 2025, an estimated $212K.
  • Regeneron Pharmaceuticals made up 0.08% of GPS Wealth Strategies Group's portfolio in Q4 2025, its #158 holding.
  • GPS Wealth Strategies Group first reported a position in Regeneron Pharmaceuticals in Q1 2021 and has held it in 19 quarters since.
  • GPS Wealth Strategies Group's Regeneron Pharmaceuticals position peaked at $664K in Q3 2024.
  • 1,388 funds tracked by Wall St. Rank held Regeneron Pharmaceuticals as of Q4 2025.

Based on GPS Wealth Strategies Group's 13F filing for Q4 2025, filed 6 Feb 2026.